drugset / Trial / NCT06436976

The Effect of Probiotics ATG-F4 in Cancer Patients

NCT06436976 ↗

NaSingle-groupOpen-labelSupportive care

Summary

Patients with advanced colorectal cancer or pancreatic cancer who are receiving oxaliplatin-based chemotherapy will be included. The research participants in this study will consume probiotics along with safety and anti-cancer agent side effect-related questionnaires, blood, and fecal sample collection for up to 12 weeks from the date of registration. The total duration of participation for research subjects is 12 weeks.

Timeline

Start
2024-03-01
Primary completion
2024-12-31
Completion
2025-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject LT-002 Unknown 4e+10 unknown —